Clinical use of checkpoint inhibition in kidney cancer.

  • Hans J. Hammers
  • Published 2016 in Clinical advances in hematology & oncology : H&O


501. 3. Hammers HJ, Plimack ER, Infante JR, et al. Expanded cohort results from CheckMate 016: a phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC) [ASCO abstract 4516]. J Clin Oncol. 2015;33(15)(suppl). 4. McDermott DF, Sznol M, Sosman JA, et al. Immune correlates and long term follow up of a phase Ia study… (More)


  • Presentations referencing similar topics